Design of VA CoronavirUs Research and Efficacy Studies-1 (VA CURES-1): A double-blind, randomized placebo-controlled trial of COVID-19 convalescent plasma in hospitalized patients with early respiratory compromise

BACKGROUND: Effective therapeutics for severe acute respiratory syndrome CoronaVirus-2 (SARS-CoV-2) infection are evolving. Under Emergency Use Authorization, COVID-19 convalescent plasma (CCP) was widely used in individuals hospitalized for COVID-19, but few randomized controlled trials supported i...

Descripción completa

Detalles Bibliográficos
Autores principales: Janoff, Edward N., Brown, Sheldon T., Belitskaya-Levy, Ilana, Curtis, Jeffrey L., Bonomo, Robert A., Miller, Elliott K., Goldberg, Alexa M., Zehm, Lisa, Wills, Ashlea, Hutchinson, Caitlin, Dumont, Larry J., Gleason, Theresa, Shih, Mei-Chiung
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Elsevier 2023
Materias:
Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10407261/
https://www.ncbi.nlm.nih.gov/pubmed/37560085
http://dx.doi.org/10.1016/j.conctc.2023.101190

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10407261/
https://www.ncbi.nlm.nih.gov/pubmed/37560085
http://dx.doi.org/10.1016/j.conctc.2023.101190

Ejemplares similares